Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
The report details the trend, potential and market size of Rufinamide market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rufinamidemarket, defines the market attractiveness level of Rufinamide market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rufinamide industry, describes the types of Rufinamide market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rufinamide market and the development prospects and opportunities of Rufinamide industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rufinamide market in Chapter 13.
By Player:
Glenmark Pharms
West-ward Pharms
Mylan
Eisai
By Type:
Tablets
Oral suspension
By End-User:
Adults
Pediatric patients
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rufinamide Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rufinamide Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rufinamide Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rufinamide Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rufinamide Market Analysis and Outlook to 2022
-
7.1 Global Rufinamide Consumption (2017-2022)
-
7.2 United States Rufinamide Consumption (2017-2022)
-
7.3 Europe Rufinamide Consumption (2017-2022)
-
7.4 China Rufinamide Consumption (2017-2022)
-
7.5 Japan Rufinamide Consumption (2017-2022)
-
7.6 India Rufinamide Consumption (2017-2022)
-
7.7 South Korea Rufinamide Consumption (2017-2022)
8 Region and Country-wise Rufinamide Market Analysis and Outlook to 2028
-
8.1 Global Rufinamide Consumption Forecast (2022-2028)
-
8.2 United States Rufinamide Consumption Forecast (2022-2028)
-
8.3 Europe Rufinamide Consumption Forecast (2022-2028)
-
8.4 China Rufinamide Consumption Forecast (2022-2028)
-
8.5 Japan Rufinamide Consumption Forecast (2022-2028)
-
8.6 India Rufinamide Consumption Forecast (2022-2028)
-
8.7 South Korea Rufinamide Consumption Forecast (2022-2028)
9 Global Rufinamide Market Outlook by Types and Applications to 2022
-
9.1 Global Rufinamide Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral suspension Consumption and Growth Rate (2017-2022)
-
9.2 Global Rufinamide Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pediatric patients Consumption and Growth Rate (2017-2022)
10 Global Rufinamide Market Outlook by Types and Applications to 2028
-
10.1 Global Rufinamide Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral suspension Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rufinamide Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pediatric patients Consumption Forecast and Growth Rate (2022-2028)
11 Global Rufinamide Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rufinamide Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rufinamide Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rufinamide Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rufinamide Market Competitive Analysis
-
14.1 Glenmark Pharms
-
14.1.1 Glenmark Pharms Company Details
-
14.1.2 Glenmark Pharms Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Glenmark Pharms Rufinamide Product and Service
-
14.2 West-ward Pharms
-
14.2.1 West-ward Pharms Company Details
-
14.2.2 West-ward Pharms Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 West-ward Pharms Rufinamide Product and Service
-
14.3 Mylan
-
14.3.1 Mylan Company Details
-
14.3.2 Mylan Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mylan Rufinamide Product and Service
-
14.4 Eisai
-
14.4.1 Eisai Company Details
-
14.4.2 Eisai Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Rufinamide Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rufinamide
-
Figure Rufinamide Picture
-
Table Global Rufinamide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rufinamide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rufinamide Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rufinamide Consumption by Country (2017-2022)
-
Figure United States Rufinamide Consumption and Growth Rate (2017-2022)
-
Table Europe Rufinamide Consumption and Growth Rate (2017-2022)
-
Figure China Rufinamide Consumption and Growth Rate (2017-2022)
-
Figure Japan Rufinamide Consumption and Growth Rate (2017-2022)
-
Figure India Rufinamide Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rufinamide Consumption and Growth Rate (2017-2022)
-
Figure Global Rufinamide Consumption Forecast by Country (2022-2028)
-
Figure United States Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rufinamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Oral suspension Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric patients Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral suspension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric patients Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rufinamide Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rufinamide Export by Region (Top 5 Countries) (2017-2028)
-
Table Glenmark Pharms (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharms Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharms Rufinamide Product and Service
-
Table West-ward Pharms (Foundation Year, Company Profile and etc.)
-
Table West-ward Pharms Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table West-ward Pharms Rufinamide Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Rufinamide Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Rufinamide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Rufinamide Product and Service
-
